HIPEC in Ovarian Cancer Care: An Advanced Treatment Option
The complexity of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) has led many to question its use because why would anyone choose such
This website aims to provide a basic understanding of peritoneal
cancers arising from different primary sites (ovaries, colon
and rectum, stomach, appendix, small intestine) and the benefit of cytoreductive surgery and HIPEC in the treatment of these cancers to patients and their caregivers.
Gastrointestinal cancers are cancers that arise from the digestive tract that includes the stomach, the esophagus, the appendix and the small and large intestines. Gastrointestinal cancers are the second most common cause of peritoneal cancer after ovarian cancer.
The peritoneum is a thin membrane that lines the inner wall of the abdominal cavity. It is an organ just like other organs of the body (the lungs, the liver, the kidneys and the brain). Cancer spread to the peritoneum is called peritoneal cancer.
Gynecological cancers are cancers that arise from a woman’s reproductive organs like the uterus, the ovaries and the fallopian tubes and the cervix. Ovarian and fallopian tube cancers are the most common source of peritoneal cancer.
Dr. Aditi Bhatt is a Surgical Oncologist with expertise in performing cytoreductive surgery and HIPEC (performed to treat pseudomyxoma peritonei, colorectal cancer, ovarian cancer, stomach cancer and others).
Here is the first-hand experience of some of the patients who were
treated by Cytoreductive Surgery and HIPEC
Sharing my thoughts on some of the most talked about topics in the field of peritoneal oncology.
The complexity of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) has led many to question its use because why would anyone choose such
Why does ovarian cancer recur?
Millions of women experience ovarian cancer worldwide each year, as it remains one of the deadliest cancer types. The year